Steqeyma Injection, Solution
Product Images NDC 72606-027

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Steqeyma (NDC 72606-027). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Celltrion Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Steqeyma 01)

An instructional diagram showing a STEQEYMA (ustekinumab-stba) prefilled syringe before and after use. The image labels syringe parts including the plunger, finger flange, viewing window, needle guard, needle, and cap, depicting the syringe with the cap on before use and needle exposed after use.*

FDA Label Image

Image (Steqeyma 02)

An instructional diagram depicting the use of a prefilled syringe to administer a subcutaneous injection. The image shows a hand holding the syringe perpendicular to the skin, with an inset close-up of the needle cap being removed or positioned.*

FDA Label Image

Image (Steqeyma 03)

An instructional illustration showing a hand holding a syringe with a needle inserted into the skin of an arm. The syringe plunger is drawn back with an arrow indicating upward movement, likely demonstrating the step of drawing back the plunger before injection.*

FDA Label Image

Figure 1 (Steqeyma 04)

A line graph titled 'PsA STUDY 1' showing the percentage of patients over 24 weeks. The x-axis represents time in weeks, and the y-axis represents percentage of patients. Three lines compare Placebo (n=206), STELARA 45 mg (n=205), and STELARA 90 mg (n=204), with both STELARA doses showing higher patient percentages than placebo throughout the study period.*

FDA Label Image

Figure A (Steqeyma 05)

Illustration showing two types of STEQEYMA prefilled syringes: one containing 45 mg/0.5 mL with a red plunger, and one containing 90 mg/mL with a blue plunger. Each syringe is displayed above a labeled box indicating the corresponding dose.*

FDA Label Image

Figure B (Steqeyma 06)

An instructional diagram showing a subcutaneous injection device for STEQEYMA (ustekinumab-stba). The 'Before Use' image labels components including the plunger, finger flange, medicine, viewing window, needle, needle guard, and cap. The 'After Use' image shows the device with the needle guard extended, illustrating the needle safely covered after injection.*

FDA Label Image

Figure C (Steqeyma 07)

An instructional illustration showing four components related to medication administration: a carton containing a prefilled syringe, a cotton ball or gauze with an alcohol swab, an adhesive bandage, and a sharps disposal container. Each component is labeled with simple line drawings.*

FDA Label Image

Figure D (Steqeyma 08)

An instructional diagram showing a carton box with a magnified view highlighting the location of the expiration date (EXP) on the package. The expiration date format is indicated as YYYY/MM.*

FDA Label Image

Figure E (Steqeyma 09)

Illustration depicting a clock showing a 30-minute interval alongside a subcutaneous injection syringe. The image suggests a 30-minute timeframe related to the administration or process involving the STEQEYMA injection solution by CELLTRION USA.*

FDA Label Image

Figure F (Steqeyma 10)

An instructional illustration depicting hands being washed under a faucet with running water, emphasizing hand hygiene or preparation steps before injection.*

FDA Label Image

Figure G (Steqeyma 11)

An illustration showing a pre-filled injection syringe with a zoomed-in view highlighting the location of the expiration date, labeled as EXP: YYYY/MM, printed on the syringe barrel. The image emphasizes where users can find the expiration date on the STEQEYMA injection device.*

FDA Label Image

Figure H (Steqeyma 12)

An instructional illustration showing a syringe filled with a solution and a close-up detail of its needle tip. The image likely relates to the injection process of a solution medication, emphasizing needle structure.*

FDA Label Image

Figure I (Steqeyma 13)

An anatomical diagram showing preferred injection sites for STEQEYMA (ustekinumab-stba) subcutaneous injection. Areas on the upper outer arms are shaded gray, indicating caregiver-only injection sites, while the abdomen and front and back of the thighs are unshaded, indicating sites suitable for self-injection or caregiver injection.*

FDA Label Image

Figure J (Steqeyma 14)

An instructional illustration showing proper technique for a subcutaneous injection into the thigh. The image depicts a person's hand pinching the skin on the upper leg, indicating the injection site for the STEQEYMA solution.*

FDA Label Image

Figure K (Steqeyma 15)

Illustration showing hands removing a needle from a syringe device, with arrows indicating the removal direction. An inset circle depicts the needle being disposed of into a puncture-resistant sharps container. This instructional diagram relates to safe needle removal and disposal for an injection product.*

FDA Label Image

Figure L (Steqeyma 16)

Illustration showing how to administer an injection with a syringe. The first image displays a hand holding a syringe at an angle, while the second image demonstrates injecting at a 45-degree angle into the skin on the back of a hand.*

FDA Label Image

Figure M (Steqeyma 17)

An instructional illustration showing a hand holding an injection device with a protective cap being removed. The image focuses on preparing the subcutaneous injection by detaching the cap from the device before administration.*

FDA Label Image

Figure N (Steqeyma 18)

An instructional illustration showing a hand holding a syringe with a protective cap being pulled off in an upward direction above a person's arm, indicating preparation for a subcutaneous injection.*

FDA Label Image

Figure N (Steqeyma 19)

An instructional illustration showing a hand about to place a syringe into a sharps disposal container. The syringe is depicted vertically above the container opening, illustrating proper disposal technique for used injection devices.*

FDA Label Image

Principal Display Panel (45 mg/0.5 mL Syringe Carton)

Packaging label for STEQEYMA (ustekinumab-stba) Injection, 45 mg/0.5 mL. The label indicates a single-dose prefilled syringe with safety guard for subcutaneous use. It contains dosage, NDC 72606-027-01, manufacturer CELLTRION, Inc., and distributor CELLTRION USA, Inc. The label includes instructions to discard unused portions and references the enclosed Medication Guide.*

FDA Label Image

Principal Display Panel (90 mg/mL Syringe Carton)

Packaging label for STEQEYMA 90 mg/mL injection, a subcutaneous solution of ustekinumab-stba. The label indicates a single-dose prefilled syringe with safety guard, manufactured by CELLTRION, Inc. and distributed by CELLTRION USA, Inc. It includes dosage information and regulatory details, featuring the brand and generic names prominently.*

FDA Label Image

Principal Display Panel (130 mg/26 mL Vial Carton)

Packaging label for STEQEYMA (ustekinumab-stba) Injection, 130 mg/26 mL (5 mg/mL) by CELLTRION USA, Inc. The label indicates it is for intravenous infusion only, single-dose vial, with storage instructions and prescription-only status. The box includes dosage and handling instructions, barcode, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.